Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
0.9700
+0.0092 (0.96%)
Feb 4, 2026, 12:50 PM EST - Market open
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $13.37 million as of February 4, 2026. Its market cap has decreased by -33.48% in one year.
Market Cap
13.37M
Enterprise Value
7.22M
1-Year Change
-33.48%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $13.37M, a decrease of -88.40%. That is a compound annual growth rate of -23.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 13.20M | -2.22% |
| Dec 31, 2025 | 13.50M | -34.47% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KALA BIO | 14.90M |
| OSR Holdings | 14.35M |
| Kairos Pharma | 13.90M |
| Hoth Therapeutics | 13.60M |
| BioLineRx | 13.49M |
| Cellectar Biosciences | 13.36M |
| BioCardia | 12.84M |
| Moleculin Biotech | 12.69M |